Sakai Yoshiki | Ono Pharmaceutical Co. LTD. Research Headquarters

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PE-494 Synthetic Prostacycline Agonist, ONO-1301, Ameliorates Left Ventricular Dysfunction and Cardiac Fibrosis in Cardiomyopathic Hamsters(PE083,Cardiovascular Pharmacology (Basic), Cost-health Care System/DPC/Laws (H),Poster Session (English),The 73rd A
A Novel Long-Lasting Prostacyclin Agonist with Thromboxane Inhibitory Activity Attenuates Monocrotaline-Induced Pulmonary Hypertension in Rats(Pulmonary Circulation 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
OE-127 Local Delivery of Slow-releasing Synthetic Prostaglandin 12 Agonist Augments Collateral Growth in Swine Chronic Cardiac Ischemia Model(Myocardial ischemia/reperfusion, basic/clinical-1, The 71st Annual Scientific Meeting of the Japanese Circulation
OE-008 Local Delivery of Slow-releasing Synthetic Prostaglandin 12 Agonist Augments Collateral Growth in Swine Chronic Cardiac Ischemia Model(Chronic coronary heart disease/Remodeling-1 (IHD) OE2,Oral Presentation (English),The 70th Anniversary Annual Sci
Local Delivery of Slow-releasing Synthetic Prostaglandin I_2 Agonist Augments Collateral Growth in Swine Chronic Cardiac Ischemia Model
Direct Injection of Synthetic Prostaglandin 12 Agonist Stimulates Expression of Endogenous Growth Factors and Inhibits Cardiac Remodeling after Myocardial Infarction(Acute Myocardial Infarction, Basic 4 (IHD), The 69th Annual Scientific Meeting of the Jap
Oral Administration of a Novel Long-Acting Prostacyclin Agonist With Thromboxane Synthase Inhibitory Activity for Pulmonary Arterial Hypertension
A Novel Long-Acting Prostacyclin Agonist (ONO-1301) With an Angiogenic Effect: Promoting Synthesis of Hepatocyte Growth Factor and Increasing Cyclic AMP Concentration via IP-Receptor Signaling
Oral Administration of a Novel Long-Acting Prostacyclin Agonist With Thromboxane Synthase Inhibitory Activity for Pulmonary Arterial Hypertension

スポンサーリンク